UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:April 01,
Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Outlook Therapeutics Charts.
Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Outlook Therapeutics Charts.

Outlook Therapeutics, Inc. News

Outlook Therapeutics® to Present at the Retina World Congress 2024
Thursday 2 May 2024 (1 day ago) • GlobeNewswire Inc.
Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
Monday 29 April 2024 (4 days ago) • GlobeNewswire Inc.
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
Monday 15 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD
Friday 22 March 2024 (1 month ago) • GlobeNewswire Inc.
Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million
Monday 18 March 2024 (2 months ago) • GlobeNewswire Inc.
Outlook Therapeutics® Announces Effective Date for 1-for-20 Reverse Stock Split
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

More Outlook Therapeutics, Inc. News Articles